top of page
AdobeStock_193266396.jpeg
EARLY STAGE MEDTECH:
Address U.S. reimbursement challenges confidently.
Hit your milestones. Land your next round.


COUSTIER ADVISORY CAN HELP.
Home: Projects
We help medtech innovators achieve widespread reimbursement coverage in the U.S.
What are your current challenges?

Securing funding by confidently addressing investor questions about reimbursement

Confirming your value proposition and business model with hospital administrators

Figuring out how to avoid expensive post-approval reimbursement clinical studies

Validating coding to ensure optimal claims processing and payment

Person holding a presentation
Doctor and Patient
Doctor Operating CT Scanner
Nurse Form

Coustier Advisory has supported medtech innovations in their earliest stages to achieve widespread reimbursement coverage in the U.S., paving the way to acquisition or IPO.

AdobeStock_193266396.jpeg

Your Questions | Our Services

EARLY-STAGE

  • Can we validate our business model with U.S. healthcare stakeholders?

  • We want to use an existing code, but the payment rate is way too low. What are our options?

  • Would payers be able to make decisions with device performance data, or do they need something else?

  • What are the strategic considerations of pursuing
    clinical trial reimbursement?

REIMBURSEMENT ASSESSMENTS

U.S. STAKEHOLDER INTERVIEWS

EVIDENCE STRATEGIES

COMMERCIALIZING

  • Do we go after payer coverage aggressively? How
    would we get in front of health plans?

  • Would we qualify for NTAP or Transitional Pass-Through?

  • How early do we need to start talking to specialty
    societies to get our own CPT code, and how can we
    influence the payment rate?

  • What do customers need in
    order to pitch our tech to Value Access Committees?

CODING & PAYMENT APPLICATIONS

PAYER ENGAGEMENT

REIMBURSEMENT SUPPORT LINES

BROADER MARKET ACCESS

  • When can we convert our tracking code to a permanent code with national payment?

  • How do we protect our favorable payment with competitors on our heels? 

  • What can our sales teams say about reimbursement?

  • We heard running programs for customers might run afoul of some anti-kickback regulations. What is the real risk?

PAYMENT POLICY ADVOCACY

PATIENT ACCESS PROGRAM DESIGN

CUSTOMER, FIELD TEAM TOOLS

"We were clueless about the U.S. reimbursement pathway, what it takes to commercialise the product. Working with Coustier Advisory, we understood how the reimbursement pathway needed to be integrated with regulatory, and more importantly, the steps and costs associated with it to realise our target." - S. Kathamachu
Home: About Me
Headshots (1).jpg

NICOLE COUSTIER

Nicole Coustier, founder of Coustier Advisory, is a veteran medtech startup advisor who has spent 20+ years helping the life sciences industry launch innovative medical technologies successfully in the U.S. 

 

​She has worked with hospitals and physicians, specialty societies and government agencies, public and private insurance health plans, sales & marketing teams and legal compliance experts, to align incentives to embrace and scale medical technology innovation in healthcare.

OTHER WAYS TO CONNECT

linkedin.png
Screenshot 2023-07-05 at 9.51.38 AM.png
Screen Shot 2022-05-09 at 12.47.39 PM.png
growthmentor-logo-8d70438cc56e3f9854c60eead94ea710.png
deepbench.png
cofounders.png
startups.png
Screenshot 2023-07-05 at 9.54.19 AM.png
Screenshot 2024-10-03 at 8.04.19 AM.png

V I S I O N

All stakeholders in the U.S. healthcare system work in partnership to improve patient outcomes.

M I S S I O N

Educate medtech on stakeholder requirements, then facilitate ways to meet those requirements.

V A L U E S

Accuracy. Transparency.
Simplicity. Reliability.
bottom of page